+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: not found
      Is Open Access

      External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results.


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          In the publication entitled “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR” (Eurosurveillance 25(8) 2020) the authors present a diagnostic workflow and RT-qPCR protocol for detection and diagnostics of 2019-nCoV (now known as SARS-CoV-2), which they claim to be validated, as well as being a robust diagnostic methodology for use in public-health laboratory settings.  In light of all the consequences resulting from this very publication for societies worldwide, a group of independent researchers performed a point-by-point review of the aforesaid publication in which 1) all components of the presented test design were cross checked, 2) the RT-qPCR protocol-recommendations were assesses w.r.t. good laboratory practice, and 3) parameters examined against relevant scientific literature covering the field.  The published RT-qPCR protocol for detection and diagnostics of 2019-nCoV and the manuscript suffer from numerous technical and scientific errors, including insufficient primer design, a problematic and insufficient RT-qPCR protocol, and the absence of an accurate test validation. Neither the presented test nor the manuscript itself fulfils the requirements for an acceptable scientific publication. Further, serious conflicts of interest of the authors are not mentioned. Finally, the very short timescale between submission and acceptance of the publication (24 hours) signifies that a systematic peer review process was either not performed here, or of problematic poor quality.  We provide compelling evidence of several scientific inadequacies, errors and flaws. Considering the scientific and methodological blemishes presented here, we are confident that the editorial board of Eurosurveillance has no other choice but to retract the publication.

          Related collections

          Author and article information

          30 November 2020
          [1 ] W+W, Lörrach, Germany
          [2 ] Department for Digital Arts, University for Applied Arts, Vienna, Austria
          [3 ] Yeadon Consulting Ltd., United Kingdom
          [4 ] FRCPAth, United Kingdom
          [5 ] Medicinal Genomics, USA
          [6 ] Department of Urology and Andrology, Biomedial Research Center of the Justus Liebig University, Giessen, Germany
          [7 ] Biochemist & Industry Pharmacologist, Loerrach, Germany
          [8 ] Società Scientifica per il Principio di Precauzione (SSPP), Italy
          [9 ] Kardiologie FMH, Wettingen, Switzerland
          [10 ] Center for Radiology of Collm Hospital Oschatz, Germany
          [11 ] Tokushima University, Japan
          [12 ] Researcher (microbiologist, nutritionist), Italy
          [13 ] Maasziekenhuis Pantein, Beugen, The Netherlands
          [14 ] DGI Consulting Services, Oslo, Norway
          [15 ] Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Germany
          [16 ] Researcher (human genetics, immunology), Munich, Germany
          [17 ] General practitioner, The Netherlands
          [18 ] Consultant Neurologist, The Netherlands
          [19 ] BDC Basel, Switzerland
          [20 ] Researcher, London, United Kingdom
          [21 ] University Hospital of Würzburg, Germany

          Creative Commons Attribution 4.0 International

          COVID-19, SARS-CoV-2, qRT-PCR


          Comment on this article